Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Myelofibrosis Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

Market Overview:

The global myelofibrosis treatment market reached a value of US$ XX Million in 2020. Looking forward, IMARC Group expects the market to grow at a CAGR of XX% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.

Myelofibrosis is a chronic leukemia disease that affects the blood-forming tissues in the body. It increases the risk of bleeding, which leads to extensive scarring in bone marrow, severe anemia, weakness, and fatigue. It can be diagnosed using physical examination, blood tests, bone marrow tests, imaging tests, and human leukocyte antigen (HLA) typing. At present, various methods of treating myelofibrosis are available, depending on the patients’ symptoms and circumstances. These methods include targeted drug therapy, chemotherapy, surgical interventions, radiation therapy, and stem cell transplantation. In addition, several drugs are being introduced that aid in reducing blood volume and providing relief from different signs and symptoms of the disease.

Myelofibrosis Treatment Market Trends:

Factors like thrombocythemia, polycythemia vera, and exposure to industrial chemicals and high levels of radiation can increase the risk of myelofibrosis. As a result, the rising occurrence of these risk factors among a significant part of the population represents one of the key factors impelling the market growth. Moreover, as primary myelofibrosis is the most diagnosed disease among people of 50 years and above, the growing geriatric population and improving diagnostic modalities are positively influencing the demand for myelofibrosis treatment methods worldwide. Apart from this, increasing sales of new drugs that can assist in relieving chronic signs and symptoms of patients are driving the market. For instance, Janus kinase (JAK) inhibitors can lessen the symptoms of an enlarged spleen, night sweats, itching, and bone pain, while immunomodulators help in the normal functioning of the immune system. Furthermore, the increasing investments in research and development (R&D) activities are anticipated to advance the knowledge of myelofibrosis disease and its treatment options and impel the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global myelofibrosis treatment market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on drug type, treatment type and end user.

Breakup by Drug Type:

  • Hydroxyurea
  • Immunomodulators
  • JAK Inhibitor
  • Others
     

Breakup by Treatment Type:

  • Blood Transfusion
  • Chemotherapy
  • Androgen Therapy
  • Stem Cell/Bone Marrow Transplantation
  • Others
     

Breakup by End User:

  • Hospitals and Clinics
  • Bone Marrow Transplant Centres
  • Others
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being AllCells LLC, American Type Culture Collection Inc, Amgen Inc, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, Gilead Sciences Inc., Incyte Corporation, Merck & Co. Inc. and Novartis AG.

Report Coverage:

Report Features Details
Base Year of the Analysis 2020
    Historical Period 2015-2020
Forecast Period 2021-2026
Units US$ Million
Segment Coverage Drug Type, Treatment Type, End User, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered AllCells LLC, American Type Culture Collection Inc, Amgen Inc, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, Gilead Sciences Inc., Incyte Corporation, Merck & Co. Inc. and Novartis AG.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Key Questions Answered in This Report:

  • How has the global myelofibrosis treatment market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global myelofibrosis treatment market?
  • What are the key regional markets?
  • What is the breakup of the market based on the drug type?
  • What is the breakup of the market based on the treatment type?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global myelofibrosis treatment market and who are the key players?
  • What is the degree of competition in the industry?

1    Preface
2    Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    Global Myelofibrosis Treatment Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Drug Type
    6.1    Hydroxyurea
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Immunomodulators
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    JAK Inhibitor
        6.3.1 Market Trends
        6.3.2 Market Forecast
    6.4    Others
        6.4.1 Market Trends
        6.4.2 Market Forecast
7    Market Breakup by Treatment Type
    7.1    Blood Transfusion
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Chemotherapy
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Androgen Therapy
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    Stem Cell/Bone Marrow Transplantation
        7.4.1 Market Trends
        7.4.2 Market Forecast
    7.5    Others
        7.5.1 Market Trends
        7.5.2 Market Forecast
8    Market Breakup by End User
    8.1    Hospitals and Clinics
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Bone Marrow Transplant Centres
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Others
        8.3.1 Market Trends
        8.3.2 Market Forecast
9    Market Breakup by Region
    9.1    North America
        9.1.1 United States
           9.1.1.1 Market Trends
           9.1.1.2 Market Forecast
        9.1.2 Canada
           9.1.2.1 Market Trends
           9.1.2.2 Market Forecast
    9.2    Asia-Pacific
        9.2.1 China
           9.2.1.1 Market Trends
           9.2.1.2 Market Forecast
        9.2.2 Japan
           9.2.2.1 Market Trends
           9.2.2.2 Market Forecast
        9.2.3 India
           9.2.3.1 Market Trends
           9.2.3.2 Market Forecast
        9.2.4 South Korea
           9.2.4.1 Market Trends
           9.2.4.2 Market Forecast
        9.2.5 Australia
           9.2.5.1 Market Trends
           9.2.5.2 Market Forecast
        9.2.6 Indonesia
           9.2.6.1 Market Trends
           9.2.6.2 Market Forecast
        9.2.7 Others
           9.2.7.1 Market Trends
           9.2.7.2 Market Forecast
    9.3    Europe
        9.3.1 Germany
           9.3.1.1 Market Trends
           9.3.1.2 Market Forecast
        9.3.2 France
           9.3.2.1 Market Trends
           9.3.2.2 Market Forecast
        9.3.3 United Kingdom
           9.3.3.1 Market Trends
           9.3.3.2 Market Forecast
        9.3.4 Italy
           9.3.4.1 Market Trends
           9.3.4.2 Market Forecast
        9.3.5 Spain
           9.3.5.1 Market Trends
           9.3.5.2 Market Forecast
        9.3.6 Russia
           9.3.6.1 Market Trends
           9.3.6.2 Market Forecast
        9.3.7 Others
           9.3.7.1 Market Trends
           9.3.7.2 Market Forecast
    9.4    Latin America
        9.4.1 Brazil
           9.4.1.1 Market Trends
           9.4.1.2 Market Forecast
        9.4.2 Mexico
           9.4.2.1 Market Trends
           9.4.2.2 Market Forecast
        9.4.3 Others
           9.4.3.1 Market Trends
           9.4.3.2 Market Forecast
    9.5    Middle East and Africa
        9.5.1 Market Trends
        9.5.2 Market Breakup by Country
        9.5.3 Market Forecast
10    SWOT Analysis
    10.1    Overview
    10.2    Strengths
    10.3    Weaknesses
    10.4    Opportunities
    10.5    Threats
11    Value Chain Analysis
12    Porters Five Forces Analysis

    12.1    Overview
    12.2    Bargaining Power of Buyers
    12.3    Bargaining Power of Suppliers
    12.4    Degree of Competition
    12.5    Threat of New Entrants
    12.6    Threat of Substitutes
13    Price Analysis
14    Competitive Landscape

    14.1    Market Structure
    14.2    Key Players
    14.3    Profiles of Key Players
        14.3.1    AllCells LLC
           14.3.1.1 Company Overview
           14.3.1.2 Product Portfolio
        14.3.2    American Type Culture Collection Inc
           14.3.2.1 Company Overview
           14.3.2.2 Product Portfolio
        14.3.3    Amgen Inc
           14.3.3.1 Company Overview
           14.3.3.2 Product Portfolio
           14.3.3.3 Financials
           14.3.3.4 SWOT Analysis
        14.3.4    Bristol-Myers Squibb Company
           14.3.4.1 Company Overview
           14.3.4.2 Product Portfolio
           14.3.4.3 Financials
           14.3.4.4 SWOT Analysis
        14.3.5    Eli Lilly and Company
           14.3.5.1 Company Overview
           14.3.5.2 Product Portfolio
           14.3.5.3 Financials
           14.3.5.4 SWOT Analysis
        14.3.6    F. Hoffmann-La Roche AG
           14.3.6.1 Company Overview
           14.3.6.2 Product Portfolio
           14.3.6.3 SWOT Analysis
        14.3.7    Gilead Sciences Inc.
           14.3.7.1 Company Overview
           14.3.7.2 Product Portfolio
           14.3.7.3 Financials
           14.3.7.4 SWOT Analysis
        14.3.8    Incyte Corporation
           14.3.8.1 Company Overview
           14.3.8.2 Product Portfolio
           14.3.8.3 Financials
           14.3.8.4 SWOT Analysis
        14.3.9    Merck & Co. Inc.
           14.3.9.1 Company Overview
           14.3.9.2 Product Portfolio
           14.3.9.3 Financials
           14.3.9.4 SWOT Analysis
        14.3.10    Novartis AG
           14.3.10.1 Company Overview
           14.3.10.2 Product Portfolio
           14.3.10.3 Financials
           14.3.10.4 SWOT Analysis

List of Figures

Figure 1: Global: Myelofibrosis Treatment Market: Major Drivers and Challenges
Figure 2: Global: Myelofibrosis Treatment Market: Sales Value (in Million US$), 2015-2020
Figure 3: Global: Myelofibrosis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 4: Global: Myelofibrosis Treatment Market: Breakup by Drug Type (in %), 2020
Figure 5: Global: Myelofibrosis Treatment Market: Breakup by Treatment Type (in %), 2020
Figure 6: Global: Myelofibrosis Treatment Market: Breakup by End User (in %), 2020
Figure 7: Global: Myelofibrosis Treatment Market: Breakup by Region (in %), 2020
Figure 8: Global: Myelofibrosis Treatment (Hydroxyurea) Market: Sales Value (in Million US$), 2015 & 2020
Figure 9: Global: Myelofibrosis Treatment (Hydroxyurea) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 10: Global: Myelofibrosis Treatment (Immunomodulators) Market: Sales Value (in Million US$), 2015 & 2020
Figure 11: Global: Myelofibrosis Treatment (Immunomodulators) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 12: Global: Myelofibrosis Treatment (JAK Inhibitor) Market: Sales Value (in Million US$), 2015 & 2020
Figure 13: Global: Myelofibrosis Treatment (JAK Inhibitor) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 14: Global: Myelofibrosis Treatment (Other Drug Types) Market: Sales Value (in Million US$), 2015 & 2020
Figure 15: Global: Myelofibrosis Treatment (Other Drug Types) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 16: Global: Myelofibrosis Treatment (Blood Transfusion) Market: Sales Value (in Million US$), 2015 & 2020
Figure 17: Global: Myelofibrosis Treatment (Blood Transfusion) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 18: Global: Myelofibrosis Treatment (Chemotherapy) Market: Sales Value (in Million US$), 2015 & 2020
Figure 19: Global: Myelofibrosis Treatment (Chemotherapy) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 20: Global: Myelofibrosis Treatment (Androgen Therapy) Market: Sales Value (in Million US$), 2015 & 2020
Figure 21: Global: Myelofibrosis Treatment (Androgen Therapy) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 22: Global: Myelofibrosis Treatment (Stem Cell/Bone Marrow Transplantation) Market: Sales Value (in Million US$), 2015 & 2020
Figure 23: Global: Myelofibrosis Treatment (Stem Cell/Bone Marrow Transplantation) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 24: Global: Myelofibrosis Treatment (Other Treatment Types) Market: Sales Value (in Million US$), 2015 & 2020
Figure 25: Global: Myelofibrosis Treatment (Other Treatment Types) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 26: Global: Myelofibrosis Treatment (Hospitals and Clinics) Market: Sales Value (in Million US$), 2015 & 2020
Figure 27: Global: Myelofibrosis Treatment (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 28: Global: Myelofibrosis Treatment (Bone Marrow Transplant Centres) Market: Sales Value (in Million US$), 2015 & 2020
Figure 29: Global: Myelofibrosis Treatment (Bone Marrow Transplant Centres) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 30: Global: Myelofibrosis Treatment (Other End Users) Market: Sales Value (in Million US$), 2015 & 2020
Figure 31: Global: Myelofibrosis Treatment (Other End Users) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 32: North America: Myelofibrosis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 33: North America: Myelofibrosis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 34: United States: Myelofibrosis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 35: United States: Myelofibrosis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 36: Canada: Myelofibrosis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 37: Canada: Myelofibrosis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 38: Asia-Pacific: Myelofibrosis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 39: Asia-Pacific: Myelofibrosis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 40: China: Myelofibrosis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 41: China: Myelofibrosis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 42: Japan: Myelofibrosis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 43: Japan: Myelofibrosis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 44: India: Myelofibrosis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 45: India: Myelofibrosis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 46: South Korea: Myelofibrosis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 47: South Korea: Myelofibrosis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 48: Australia: Myelofibrosis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 49: Australia: Myelofibrosis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 50: Indonesia: Myelofibrosis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 51: Indonesia: Myelofibrosis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 52: Others: Myelofibrosis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 53: Others: Myelofibrosis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 54: Europe: Myelofibrosis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 55: Europe: Myelofibrosis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 56: Germany: Myelofibrosis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 57: Germany: Myelofibrosis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 58: France: Myelofibrosis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 59: France: Myelofibrosis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 60: United Kingdom: Myelofibrosis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 61: United Kingdom: Myelofibrosis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 62: Italy: Myelofibrosis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 63: Italy: Myelofibrosis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 64: Spain: Myelofibrosis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 65: Spain: Myelofibrosis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 66: Russia: Myelofibrosis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 67: Russia: Myelofibrosis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 68: Others: Myelofibrosis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 69: Others: Myelofibrosis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 70: Latin America: Myelofibrosis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 71: Latin America: Myelofibrosis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 72: Brazil: Myelofibrosis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 73: Brazil: Myelofibrosis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 74: Mexico: Myelofibrosis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 75: Mexico: Myelofibrosis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 76: Others: Myelofibrosis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 77: Others: Myelofibrosis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 78: Middle East and Africa: Myelofibrosis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 79: Middle East and Africa: Myelofibrosis Treatment Market: Breakup by Country (in %), 2020
Figure 80: Middle East and Africa: Myelofibrosis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 81: Global: Myelofibrosis Treatment Industry: SWOT Analysis
Figure 82: Global: Myelofibrosis Treatment Industry: Value Chain Analysis
Figure 83: Global: Myelofibrosis Treatment Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Myelofibrosis Treatment Market: Key Industry Highlights, 2020 and 2026
Table 2: Global: Myelofibrosis Treatment Market Forecast: Breakup by Drug Type (in Million US$), 2021-2026
Table 3: Global: Myelofibrosis Treatment Market Forecast: Breakup by Treatment Type (in Million US$), 2021-2026
Table 4: Global: Myelofibrosis Treatment Market Forecast: Breakup by End User (in Million US$), 2021-2026
Table 5: Global: Myelofibrosis Treatment Market Forecast: Breakup by Region (in Million US$), 2021-2026
Table 6: Global: Myelofibrosis Treatment Market: Competitive Structure
Table 7: Global: Myelofibrosis Treatment Market: Key Players

Note: We value your privacy and will never rent or sell your email address. Privacy policy

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2299

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links